Systemische Therapie des metastasierten Blasenkarzinoms

Translated title of the contribution: Systemic therapy of metastatic bladder cancer

M. Retz*, S. C. Schmid, M. W. Kramer, A. S. Merseburger

*Corresponding author for this work

Abstract

This review focuses on current options in the medical therapy of metastasized urothelial carcinoma of the bladder. Standard treatments as well as new, recently published therapeutic approaches are evaluated and discussed.

Translated title of the contributionSystemic therapy of metastatic bladder cancer
Original languageGerman
JournalUrologe - Ausgabe A
Volume52
Issue number11
Pages (from-to)1541-1546
Number of pages6
ISSN0340-2592
DOIs
Publication statusPublished - 11.2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

Fingerprint

Dive into the research topics of 'Systemic therapy of metastatic bladder cancer'. Together they form a unique fingerprint.

Cite this